Your browser doesn't support javascript.
loading
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis.
Savitski, Mikhail M; Zinn, Nico; Faelth-Savitski, Maria; Poeckel, Daniel; Gade, Stephan; Becher, Isabelle; Muelbaier, Marcel; Wagner, Anne J; Strohmer, Katrin; Werner, Thilo; Melchert, Stephanie; Petretich, Massimo; Rutkowska, Anna; Vappiani, Johanna; Franken, Holger; Steidel, Michael; Sweetman, Gavain M; Gilan, Omer; Lam, Enid Y N; Dawson, Mark A; Prinjha, Rab K; Grandi, Paola; Bergamini, Giovanna; Bantscheff, Marcus.
Afiliación
  • Savitski MM; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany; Genome Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany. Electronic address: mikhail.savitski@embl.de.
  • Zinn N; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Faelth-Savitski M; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Poeckel D; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Gade S; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Becher I; Genome Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
  • Muelbaier M; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Wagner AJ; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Strohmer K; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Werner T; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Melchert S; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Petretich M; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Rutkowska A; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Vappiani J; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Franken H; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Steidel M; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Sweetman GM; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia.
  • Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia.
  • Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia.
  • Prinjha RK; Epinova DPU, Immuno-Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK.
  • Grandi P; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
  • Bergamini G; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany. Electronic address: giovanna.2.bergamini@gsk.com.
  • Bantscheff M; Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany. Electronic address: marcus.x.bantscheff@gsk.com.
Cell ; 173(1): 260-274.e25, 2018 03 22.
Article en En | MEDLINE | ID: mdl-29551266
ABSTRACT
Protein degradation plays important roles in biological processes and is tightly regulated. Further, targeted proteolysis is an emerging research tool and therapeutic strategy. However, proteome-wide technologies to investigate the causes and consequences of protein degradation in biological systems are lacking. We developed "multiplexed proteome dynamics profiling" (mPDP), a mass-spectrometry-based approach combining dynamic-SILAC labeling with isobaric mass tagging for multiplexed analysis of protein degradation and synthesis. In three proof-of-concept studies, we uncover different responses induced by the bromodomain inhibitor JQ1 versus a JQ1 proteolysis targeting chimera; we elucidate distinct modes of action of estrogen receptor modulators; and we comprehensively classify HSP90 clients based on their requirement for HSP90 constitutively or during synthesis, demonstrating that constitutive HSP90 clients have lower thermal stability than non-clients, have higher affinity for the chaperone, vary between cell types, and change upon external stimuli. These findings highlight the potential of mPDP to identify dynamically controlled degradation mechanisms in cellular systems.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas HSP90 de Choque Térmico / Proteoma / Proteómica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas HSP90 de Choque Térmico / Proteoma / Proteómica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article